Wilson Sonsini Goodrich & Rosati’s 2017 Technology and Life Sciences IPO Report sets forth data related to 61 U.S.-based technology and life sciences initial public offerings that priced between January 1 and December 15, 2017. The report reflects what eventually proved to be a moderately active year for tech and life sciences issuers. However, it took all four quarters to reach a higher number of IPOs than the 49 offerings that were included in WSGR’s 2016 IPO Report. Like the previous year, technology and life sciences IPOs were off to a slow start in 2017, with only six such offerings completed in the first quarter. Activity accelerated in Q2 with 20 IPOs before dropping off sharply in Q3, even though there were still 10 IPOs during the quarter, nine of which were in the life sciences sector. The year ended with a flurry, with 25 tech and life sciences IPOs pricing during Q4, compared to only eight such offerings during the last quarter of 2016.